Ji Hoon Kim - Concepedia

Author

Ji Hoon Kim

Also Known As

Beom Jae Lee, Dae Young Zang, H C Kim, Hayeon Kim, Hyo Jung Kim, Hyung-Lae Kim, Hyung-Yong Kim, Hyunghwan Kim, In Ho Kim, In Kim

2.6K

Publications

18.2K

Citations

H-Index

287

Concepts

All Affiliations

Korea University Korea University Medical Center Yonsei University University of Ulsan Ulsan College

About

Ji Hoon Kim is an author at Korea University specializing in medicine, hepatology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	25	50	1.9K
2	Engineering	10	11	274
3	Health Sciences	10	11	622
4	Education	2	2	46
5	Natural Sciences	2	2	146

Ji Hoon Kim

209

Publications

9.3K

Citations

H-Index

Page 1

	Year	Citations
Melasma: histopathological characteristics in 56 Korean patients Won-Ho Kang, Kun‐Ho Yoon, Eun‐So Lee, British Journal of Dermatology	2002	402
A Prospective Evaluation of<sup>18</sup>F-FDG and<sup>11</sup>C-Acetate PET/CT for Detection of Primary and Metastatic Hepatocellular Carcinoma Joong-Won Park, Ji Hoon Kim, Seok Ki Kim, Journal of Nuclear Medicine	2008	277
Association between increment of serum VEGF level and prognosis after transcatheter arterial chemoembolization in hepatocellular carcinoma patients Ju Hyun Shim, Joong‐Won Park, Ji Hoon Kim, Cancer Science	2008	241
Exosomes derived from palmitic acid-treated hepatocytes induce fibrotic activation of hepatic stellate cells Young‐Sun Lee, So Yeon Kim, Eunjung Ko, Scientific Reports	2017	235
The Prospective Randomized, Controlled Trial of Endoscopic Ultrasound-Guided Fine-Needle Aspiration Using 22G and 19G Aspiration Needles for Solid Pancreatic or Peripancreatic Masses Tae Jun Song, Ji Hoon Kim, Sang Soo Lee, The American Journal of Gastroenterology	2010	194
Quantitative Assessment of Pancreatic Fat by Using Unenhanced CT: Pathologic Correlation and Clinical Implications So Yeon Kim, Haeryoung Kim, Jai Young Cho, Radiology	2014	192
Transarterial chemoembolisation combined with lenvatinib plus pembrolizumab versus dual placebo for unresectable, non-metastatic hepatocellular carcinoma (LEAP-012): a multicentre, randomised, double-blind, phase 3 study Masatoshi Kudo, Zhenggang Ren, Yabing Guo, The Lancet HepatologyNon-metastatic Hepatocellular CarcinomaTransarterial ChemoembolisationMedicinePharmacology	2025	161
Yes‐associated protein 1 and transcriptional coactivator with PDZ‐binding motif activate the mammalian target of rapamycin complex 1 pathway by regulating amino acid transporters in hepatocellular carcinoma Yun‐Yong Park, Bo Hwa Sohn, Randy L. Johnson, Hepatology	2015	156
PPAR agonists treatment is effective in a nonalcoholic fatty liver disease animal model by modulating fatty‐acid metabolic enzymes Yeon Seok Seo, Ji Hoon Kim, Nam Young Jo, Journal of Gastroenterology and Hepatology	2006	149
Hepatic stellate cell and monocyte interaction contributes to poor prognosis in hepatocellular carcinoma Juling Ji, Tobias Eggert, Anuradha Budhu, Hepatology	2015	146

Page 1